semaglutide oral bioavailability Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? A Pharmacological and Clinical Overview

Description

GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are not recommended during pregnancy

As peptide-based products become more visible in international markets, counterfeit packaging and cloned verification systems have also increased significantly

Oral semaglutide offers a dual benefitaddressing both glycemic control and cardiovascular risk.Martin Holst Lange, Executive Vice President for Development at Novo Nordisk, stated, These data reinforce the comprehensive set of health benefits of semaglutide, making it a strong option for healthcare professionals addressing the spectrum of metabolic and cardiovascular health.The SOUL trial confirmed the established safety and tolerability of oral semaglutide, with no new safety concerns identified and long-term safety data covering over 33 million patient years.Dr A.K